Live vaccine preserved at room temperature: Preparation and characterization of a freeze-dried classical swine fever virus vaccine

Xiao-Xin Zuo,Yan-Hong Zhao,Ming-Xu Zhou,Bi-Hua Deng,Lai-Gen Hu,Fang Lv,Yu Lu,Ji-Bo Hou,Xiao-xin Zuo,Yan-hong Zhao,Ming-xu Zhou,Bi-hua Deng,Lai-gen Hu,Ji-bo Hou
DOI: https://doi.org/10.1016/j.vaccine.2020.10.093
IF: 4.169
2020-12-01
Vaccine
Abstract:<p>The heat-stable live-attenuated classical swine fever virus (CSFV) vaccine is an urgent need in many countries of Asia, Europe and Latin America. In this study, the thermostability of lyophilized live-attenuated CSFV vaccine formulations were investigated using accelerated stability at 37 °C for 10 days. The freeze-dried heat-stable formulation ST16, containing excipient combinations of trehalose, glycine, thiourea and phosphate buffer shows the superior thermostability. Moreover, the lyophilized vaccine with formula ST16 kept loss of viral activity less than 0.5 log<sub>10</sub> during 24 months at storage temperatures of 2–8 °C. In thermal study, ST16 stabilized the vaccine within 1.0 log<sub>10</sub> loss after storage at up to 25 °C for 6 months and room temperature for 7 months. Even under the harshest storage conditions of 37 °C for 25 days and 45 °C for 2 weeks, the virus titer dropped less than 1.0 log<sub>10</sub> using ST16. Besides, it is notable that ST16 excluded gelatin and exogenous proteins, which might cause allergic reactions, thus avoiding immune side effects. The vaccine formulated ST16 proved to be safe and effective when immunized to piglets in vivo. The characteristics of dried vaccines were analyzed by X-ray powder diffraction, residual water measurements, differential scanning calorimetry and it was found that vaccine antigen were preserved in an amorphous matrix with high glass transition temperature above 60 °C and low residual water content below 2%, which made the vaccine more stable during storage.</p>
immunology,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to predict the long - term survival rate of patients with left ventricular dysfunction after coronary artery bypass grafting (CABG) by using iodophenol valeric acid (IPPA). Specifically, the study aims to evaluate the ability of IPPA in identifying viable myocardial regions and explore the relationship between the number of these viable regions and the two - year post - operative survival rate of patients. The study found that patients with more IPPA - defined viable myocardial segments had a significantly higher post - operative survival rate than those with fewer viable segments. This finding is of great significance for guiding clinical decision - making, especially in selecting which patients are likely to benefit the most from CABG surgery.